| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Hormone Biochemistry Department, Imperial Cancer Research Fund, P. O. Box 123, Lincoln's Inn Fields, London, WC2A 3PX England
Conditions are described for growing and maintaining the estradiol sensitivity of the human breast cancer cell line ZR-75-1 both in monolayer and suspension cultures. Either newborn calf or fetal calf serum can be used in the culture medium, but an effect of estradiol on growth of the cells was only observed reproducibly if the serum was first treated with dextran-charcoal. Sulfatase treatment of the sera prior to dextrancharcoal treatment did not decrease cell growth in the absence of added estradiol, indicating that estrogen sulfates are unlikely to contribute to cell growth in dextran-charcoal-treated sera.
In monolayer cultures, estradiol increased both the growth rate and final saturation density of the cells for each individual plating density tested in a dose-dependent manner with maximal stimulation occurring between 10-10 and 10-8 M estradiol. Estradiol also markedly increased the ability of the cells to grow both in suspension and semisolid Methocel cultures. In suspension, the cells grew as tight balls which clustered together to give small organoid-like structures reaching diameters of 4 mm and composed of an outer shell of living cells containing a central cavity of necrotic cells.
In the absence of estradiol in both monolayer and suspension, the cells went through a limited and constant number of divisions and then stopped, such that the final cell number was determined by the initial plating density. In the presence of estradiol, this block was removed such that in monolayer cultures the final cell number was independent of plating density. A major loss of estradiol response was found if the cells were grown for 7 to 14 days in the absence of estradiol. This loss of response appeared to be due to a loss of ability to grow rather than to selective cell death within the population.
1 To whom requests for reprints should be addressed.
2 Present address: Cell Biology Division, Glaxo Group Research, Greenford Road, Greenford, Middlesex, England.
Received 5/17/82. Accepted 10/ 7/82.
This article has been cited by other articles:
|
|
 |
|
  D Pugazhendhi, K A Watson, S Mills, N Botting, G S Pope, and P D Darbre Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells J. Endocrinol., June 1, 2008; 197(3): 503 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-A. Martin, J. E. Head, S. Pancholi, J. Salter, E. Quinn, S. Detre, S. Kaye, A. Howes, M. Dowsett, and S. R.D. Johnston The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo Mol. Cancer Ther., September 1, 2007; 6(9): 2458 - 2467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L-A Martin, S Pancholi, C M W Chan, I Farmer, C Kimberley, M Dowsett, and S R D Johnston The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling Endocr. Relat. Cancer, December 1, 2005; 12(4): 1017 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Liu, P. S. Rudland, D. R. Sibson, A. Platt-Higgins, and R. Barraclough Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas Cancer Res., May 1, 2005; 65(9): 3796 - 3805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Steddon, C. W. McIntyre, N. J. Schroeder, J. M. Burrin, and J. Cunningham Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3078 - 3083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M J Currie, V Hanrahan, S P Gunningham, H R Morrin, C Frampton, C Han, B A Robinson, and S B Fox Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1{alpha}) and the HIF-1{alpha} target gene DEC1, but not lymph node metastasis in primary human breast carcinomas J. Clin. Pathol., August 1, 2004; 57(8): 829 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gu, R. Y. Lee, T. C. Skaar, K. B. Bouker, J. N. Welch, J. Lu, A. Liu, Y. Zhu, N. Davis, F. Leonessa, et al. Association of Interferon Regulatory Factor-1, Nucleophosmin, Nuclear Factor-{kappa}B, and Cyclic AMP Response Element Binding with Acquired Resistance to Faslodex (ICI 182,780) Cancer Res., June 1, 2002; 62(12): 3428 - 3437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Stephen, L. E. Shaw, C. Larsen, D. Corcoran, and P. D. Darbre Insulin-like Growth Factor Receptor Levels Are Regulated by Cell Density and by Long Term Estrogen Deprivation in MCF7 Human Breast Cancer Cells J. Biol. Chem., October 19, 2001; 276(43): 40080 - 40086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. James, T. C. Skaar, R. Y. Lee, A. MacPherson, J. A. Zwiebel, B. S. Ahluwalia, F. Ampy, and R. Clarke Constitutive Expression of the Steroid Sulfatase Gene Supports the Growth of MCF-7 Human Breast Cancer Cells in Vitro and in Vivo Endocrinology, April 1, 2001; 142(4): 1497 - 1505. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Currie, S. P. Gunningham, C. Han, P. A. E. Scott, B. A. Robinson, A. L. Harris, and S. B. Fox Angiopoietin-1 Is Inversely Related to Thymidine Phosphorylase Expression in Human Breast Cancer, Indicating a Role in Vascular Remodeling Clin. Cancer Res., April 1, 2001; 7(4): 918 - 927. [Abstract] [Full Text]
|
|
|
|
|
|
W. Xie, R. Duan, I. Chen, I. Samudio, and S. Safe Transcriptional Activation of Thymidylate Synthase by 17{beta}-Estradiol in MCF-7 Human Breast Cancer Cells Endocrinology, July 1, 2000; 141(7): 2439 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Inadera, T. Sekiya, T. Yoshimura, and K. Matsushima Molecular Analysis of the Inhibition of Monocyte Chemoattractant Protein-1 Gene Expression by Estrogens and Xenoestrogens in MCF-7 Cells Endocrinology, January 1, 2000; 141(1): 50 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gutman, S. Couillard, F. Labrie, B. Candas, and C. Labrie Effects of the Antiestrogen EM-800 (SCH 57050) and Cyclophosphamide Alone and in Combination on Growth of Human ZR-75-1 Breast Cancer Xenografts in Nude Mice Cancer Res., October 1, 1999; 59(20): 5176 - 5180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Jun, Z. Chen, M. C. Pace, and P. W. Shaul Glucocorticoids Downregulate Cyclooxygenase-1 Gene Expression and Prostacyclin Synthesis in Fetal Pulmonary Artery Endothelium Circ. Res., February 5, 1999; 84(2): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. MacRitchie, S. S. Jun, Z. Chen, Z. German, I. S. Yuhanna, T. S. Sherman, and P. W. Shaul Estrogen Upregulates Endothelial Nitric Oxide Synthase Gene Expression in Fetal Pulmonary Artery Endothelium Circ. Res., September 19, 1997; 81(3): 355 - 362. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. K. K. El-Tanani and C. D. Green Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor Mol. Endocrinol., June 1, 1997; 11(7): 928 - 937. [Abstract] [Full Text]
|
|
|
|
|
|
A. Stoica, M. Saceda, A. Fakhro, H. B. Solomon, B. D. Fenster, and M. B. Martin The Role of Transforming Growth Factor-{beta} in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line Endocrinology, April 1, 1997; 138(4): 1498 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Phippard, S. Weber-Hall, P. Sharpe, M. Naylor, H Jayatalake, R Maas, I Woo, D Roberts-Clark, P. Francis-West, Y. Liu, et al. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development Development, January 9, 1996; 122(9): 2729 - 2737. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Ervin Jr, M. Kaminski, R. Cody, and M. Wicha Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells Science, June 30, 1989; 244(4912): 1585 - 1587. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Shapira, E. Virolainen, J. J. Jameson, S. J. Ossakow, and T. E. Carey Growth Inhibition of Laryngeal UM-SCC Cell Lines by Tamoxifen: Comparison With Effects on the MCF-7 Breast Cancer Cell Line Arch Otolaryngol Head Neck Surg, November 1, 1986; 112(11): 1151 - 1158. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
